The London-based company said the FDA had approved its lead product Ferracru/Accrufer (ferric maltol) in a market that could be worth $1 billion annually. The FDA approved the product for ...
Under his guidance, the Company has experienced increases in revenues and net pricing for ACCRUFeR® in the United States and fostered strengthened relationships with key partners and shareholders.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Pharmaceutical company Shield Therapeutics, which has a base in Gateshead, has officially appointed a chief executive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results